Clinical evidence on the efficacy and tolerability of a topical medical device containing benzoylperoxide 4%, retinol 0.5%, mandelic acid 1% and lactobionic acid 1% in the treatment of mild facial acne: an open label pilot study.

Garofalo, Virginia; Cannizzaro, Maria Vittoria; Mazzilli, Sara; Bianchi, Luca; Campione, Elena

Garofalo, Virginia; Cannizzaro, Maria Vittoria; Mazzilli, Sara; Bianchi, Luca; Campione, Elena.

Afiliação

Garofalo V; Division of Dermatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Cannizzaro MV; Division of Dermatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Mazzilli S; Division of Dermatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Bianchi L; Division of Dermatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Campione E; Division of Dermatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

Clin Cosmet Investig Dermatol ; 12: 363-369, 2019.

Article em En | MEDLINE | ID: mdl-31190944

Palavras-chave

acne vulgaris; alpha hydroxide acid; benzoyl peroxide; therapeutics; vitamin A

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Cosmet Investig Dermatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google